글로벌 세포 건강 검진 시장 – 2029년까지의 산업 동향 및 예측

세포 건강 검진 시장 분석 및 규모

세계보건기구 보고서에 따르면 전 세계적으로 만성 질환이 더 많다고 합니다. 2001년에 만성 질환은 전 세계 질병 부담의 약 46%를 차지했고 전 세계적으로 발생한 5,650만 명의 사망자 중 60%를 차지했습니다. 전 세계적으로 만성 질환이 증가함에 따라 시장 확장이 촉진될 것으로 예상됩니다.

Data Bridge Market Research는 2021년에 22억 6천만 달러였던 세포 건강 검진 시장이 2029년까지 57억 2천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 12.30%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

세포 건강 검진 시장 범위 및 세분화      

시장 정의

Cellular toxicity, fat mass, cellular health and function, intra and extracellular fluid levels, and muscle mass quality can all be determined with the help of cellular health screening.

Cellular Health Screening Market Dynamics

Drivers

• Rise in chronic diseases

The market is anticipated to develop faster as telomere performance programmes become more widely adopted. The market for cellular health screening will grow more quickly between 2022 and 2029 due to a number of additional factors, including an increase in chronic disease cases, an increase in research activities, a growing emphasis on healthy life expectancy, an increase in the population's average age, and an increase in the adoption of digital testing technologies.

• Rise in geriatric population

Growing geriatric population and consequent growth in the need for cellular health screening, rising geriatric population, growing adoption of the direct-to-consumer approach, growing importance of healthy life expectancy (HALE), rising government focus towards preventive healthcare, increasing telomere performance programmes for leading a healthy life, and growing burden of chronic diseases are expected to drive the growth of this market.

Opportunities

The need for testing solutions based on preventative healthcare has increased as a result of an increase in awareness campaigns by organisations around the world. One of the major key factors anticipated to propel market expansion in the near future is collaboration efforts made by organisations like the WHO, CDC, U.S. Preventive Services Task Force, and National Cervical Cancer Coalition to promote cervical cancer screening.

Restraints/Challenges

On the other hand, rising problem associated with the transport of samples, unfavourable reimbursement policies and difference in the cost kit offered by different organization is expected to hamper the market's growth rate.

This cellular health screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cellular health screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cellular Health Screening Market

Market participants noticed a drop in their sales and base testing volume as a result of the COVID-19 epidemic. Additionally, the pandemic-related government mandates and restrictions on the transportation, export, and import of goods, raw materials, etc. disrupt the supply chain. The demand has decreased as a result, but many businesses have diversified their product lines to include COVID-19 molecular and antibody testing, which can equally counteract the decline in base testing volume.

Global Cellular Health Screening Market Scope

The cellular health screening market is segmented on the basis of type, sample type, and sample collection site. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Single Test Panels
• Telomere Tests
• Oxidative Stress Tests
• Inflammation Tests
• Heavy Metals Tests
• Multi-test Panels

Sample Test

• Blood
• Saliva
• Serum
• Urine

Collection Sites

• Home
• Office
• Hospital
• Diagnostic Labs

 Cellular Health Screening Market Regional Analysis/Insights

The cellular health screening market is analysed and market size insights and trends are provided by country, type, sample type, and sample collection site as referenced above.

The countries covered in the cellular health screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cellular health screening market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising ageing population and increasing government initiatives to enhance the healthy lifestyles.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

경쟁 환경 및 세포 건강 검진 시장 점유율 분석

세포 건강 검진 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 세포 건강 검진 시장과 관련된 회사의 초점에만 관련이 있습니다.

세포 건강 검진 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 제노바 다이어그노스틱스(미국)
• 텔로미어 진단(미국)
• Life Length (스페인)
• Quest Diagnostics Incorporated(미국)
• Dx 반복(캐나다)
• SpectraCell Laboratories Inc. (미국)
• 지메트리(미국)
• 셀 사이언스 시스템(미국)
• 티타노보 주식회사(미국)
• 세그테라 주식회사(미국)
• Laboratory Corporation of America Holdings (미국)
• 바이오레퍼런스(미국)
• Immundiagnostik AG(독일)
• 클리블랜드 하트랩(Cleveland HeartLab, Inc.) (미국)

SKU-53060